289 Immune cell population of cutaneous neurofibromas

نویسندگان

چکیده

Neurofibromatosis 1 (NF1) is one of the most common genodermatoses and cutaneous neurofibromas (cNFs) manifest in almost every adult with NF1. The immune microenvironment cNFs incompletely known. A total 60 from ten patients NF1 were used for immunolabeling. Tumor T-cells visualized counted based on positive reaction CD3, CD4, CD8 FoxP3. CD68 CD163 to detect macrophages. aggregation cells at tumor margin was separately assessed topmost part covered by epidermis. Nine analysed separating overlying skin tumor, isolating genomic DNA both tissues. T cell receptor (TCR) CDR domain sequenced compare profiles skin. Mass spectrometric analysis 15 performed expression inflammation-related pathways cNF. Intratumoral detected all samples, T-cell population clearly CD4-dominant. Most samples displayed CD3 area underlying density macrophages higher older (P=0.019). suggestive M2 abundant cNFs. TCR sequencing showed that populations distinct. number productive rearrangements observed (mean 1,200) significantly lower compared 5,190; P<0.001). mass spectrometry data many processes related downregulated This study gives an overview paves way detailed studies elucidate potential therapeutic targets treatment or prevention growth

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Mast cell numbers in melanocytic naevi and cutaneous neurofibromas.

This study aimed to determine the diagnostic utility of mast cell densities in distinguishing neurotised ("neural") melanocytic naevi from neurofibromas. Three groups of lesions were studied: neurofibromas, neural naevi, and naevi showing no neural change (control naevi). A Giemsa stain was used to demonstrate mast cells. The median mast cell density in the neurotised naevus group was significa...

متن کامل

Carbon Dioxide Laser Treatment of Cutaneous Neurofibromas

INTRODUCTION Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder, with multisystem involvement, including cutaneous manifestations of hyperpigmentation and neurofibromas. Multiple cutaneous lesions are often disfiguring and lead to emotional distress and social isolation. Treatment of NF1 is predominantly surgical but alternative treatments should be considered for patients with la...

متن کامل

Retrospective study of 289 odontogenic tumors in a Brazilian population

Background: Odontogenic tumors (OTs) are considered important among oral lesions because of their clinicopathological heterogeneity, and variable biological behavior. This paper aims to determine the frequency and distribution of OTs, over a period of 10 years, at a public university in Northeastern Brazil and compare this data with previous reports. Material and Methods: We reviewed all cases ...

متن کامل

A high-throughput molecular data resource for cutaneous neurofibromas

Neurofibromatosis type 1 (NF1) is a genetic disorder with a range of clinical manifestations such as widespread growth of benign tumours called neurofibromas, pain, learning disorders, bone deformities, vascular abnormalities and even malignant tumours. With the establishment of the Children's Tumour Foundation biobank, neurofibroma samples can now be collected directly from patients to be anal...

متن کامل

Retrospective study of 289 odontogenic tumors in a Brazilian population.

BACKGROUND Odontogenic tumors (OTs) are considered important among oral lesions because of their clinicopathological heterogeneity, and variable biological behavior. This paper aims to determine the frequency and distribution of OTs, over a period of 10 years, at a public university in Northeastern Brazil and compare this data with previous reports. MATERIAL AND METHODS We reviewed all cases ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Investigative Dermatology

سال: 2022

ISSN: ['1523-1747', '0022-202X']

DOI: https://doi.org/10.1016/j.jid.2022.09.301